Yasuo Urata
Founder at ONCOLYS BIOPHARMA INC.
Net worth: 2 M $ as of 31/05/2024
Yasuo Urata active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ONCOLYS BIOPHARMA INC. | Director/Board Member | 18/03/2004 | - |
| Chief Tech/Sci/R&D Officer | 18/03/2004 | - | |
| Founder | 18/03/2004 | - | |
| President | 18/03/2004 | - | |
| Oncolys USA, Inc. | Chairman | 01/08/2016 | - |
Career history of Yasuo Urata
Former positions of Yasuo Urata
| Companies | Position | Start | End |
|---|---|---|---|
| JAPAN TOBACCO, INC. | Corporate Officer/Principal | 01/01/1994 | - |
| ONO PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - | - |
| WONIK CUBE CORP. | Director/Board Member | 26/09/2011 | - |
| Independent Dir/Board Member | 26/09/2011 | - | |
Tacere Therapeutics, Inc.
 Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Director/Board Member | 01/07/2007 | - |
Training of Yasuo Urata
| Kyoto Pharmaceutical University | Graduate Degree |
| Tokai High School | Undergraduate Degree |
Statistics
International
| Japan | 6 |
| United States | 3 |
| South Korea | 2 |
Operational
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| JAPAN TOBACCO, INC. | Consumer Non-Durables |
| ONO PHARMACEUTICAL CO., LTD. | Health Technology |
| WONIK CUBE CORP. | Distribution Services |
| ONCOLYS BIOPHARMA INC. | Health Technology |
| Private companies | 2 |
|---|---|
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tacere Therapeutics, Inc. provides treatment of infectious diseases. It develops novel therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company was founded by Sara M. Hall, Amit J. Kumar, John James Monahan, and Michael J. Catelani in 2006 and is headquartered in San Jose, CA. | Health Technology |
| Oncolys USA, Inc. |
- Stock Market
- Insiders
- Yasuo Urata
- Experience
